Ausgabe 4/2021
Inhalt (23 Artikel)
ASCO 2021: Highlights in central nervous system tumors
- Open Access
- ASCO 2021
- short review
Maximilian J. Mair, Anna S. Berghoff
Best of ASCO 2021: new data from triple-negative breast cancer
- Open Access
- ASCO 2021
- short review
Christian Singer
ASCO 2021 highlights head and neck cancer: nasopharyngeal carcinoma
- Open Access
- ASCO 2021
- short review
Thorsten Fuereder
Ovarian cancer—ASCO annual meeting update 2021
- ASCO 2021
- short review
Johannes Schöche, Kathrin Strasser-Weippl
ASCO 2021—selection of personal highlights in early stage non-small cell lung cancer
- Open Access
- ASCO 2021
- review
Gudrun Absenger, Andreas Pircher
Practical considerations for the management of immune thrombocytopenic purpura
- review
Michael Fillitz, Barbara Dixer, Felix Keil
Value of autophagy-related gene 5 (ATG5) expression as a prognostic marker in adults with newly diagnosed acute lymphoblastic leukaemia (ALL)
- original report
Rasha I. Ibrahim, Haydi S. Mohamed, Mary G. Nagib, Hebatullah M. Fares, Alia M. Saeed
The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours
- comment
Wolfgang Jungraithmayr
Unresectable pleural mesothelioma—hope or still an unmet medical need?
- Open Access
- short review
Gudrun Absenger, Angelika Terbuch
Neuroendocrine neoplasms of the lung: a pathology update
- Open Access
- short review
Jasna Metovic, Marco Barella, Giuseppe Pelosi
Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib
- case report
Louisa Hempel, Jakob Molnar, Andreas Gaumann, Sebastian Robert, Josef Scheiber, Axel Kleespies, Kristina Riedmann, Susanne Schreiber, Beate Gandorfer, Armin Piehler, Dirk Hempel
Rare lung cancers—Primary pulmonary leiomyosarcoma: A case report
- Open Access
- case report
Laurenz Nagl, Andreas Seeber, Gerlig Widmann, Katja Schmitz, Herbert Maier, Georg Pall, Dominik Wolf, Andreas Pircher
The value of immunotherapy in pediatric leukemia and lymphoma
- Open Access
- short review
Elisabeth Salzer, Andishe Attarbaschi
Ponatinib and palbociclib combination in TKI-resistant CML—A case report
- case report
Johannes B. Jaeger, Thomas Jaeger, Sandra Preuner, Petra Pusic, Isabella Sponseiler, Thomas Lion, Thomas Winder, Bernd Lorenz Hartmann
